The relative expression level of Ki67 in the tumor treated with FUS-activated cyaninplatin drastically declined to 24% of that in the untreated group, where the level in the tumor treated with carboplatin and ligand 1 remained at 49% (fig. This evidence concerns the gene MKI67 and neoplasm.